Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare data

被引:0
|
作者
Rahman, Fariha [1 ]
Osazuwa-Peters, Oyomoare L. [1 ]
Meernik, Clare [1 ]
Ward, Kevin C. [2 ]
Kuliszewski, Margaret G. [3 ]
Huang, Bin [4 ,5 ]
Berchuck, Andrew [6 ]
Tucker, Thomas [5 ,7 ]
Pisu, Maria [8 ,9 ]
Liang, Margaret [10 ]
Akinyemiju, Tomi F. [1 ,11 ]
机构
[1] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC 27708 USA
[2] Emory Univ, Georgia Canc Registry, Atlanta, GA USA
[3] New York State Dept Hlth, New York State Canc Registry, Albany, NY USA
[4] Univ Kentucky, Div Canc Biostat, Lexington, KY USA
[5] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA
[6] Duke Div Gynecol Oncol, Durham, NC USA
[7] Univ Kentucky, Dept Epidemiol & Environm Hlth, Lexington, KY USA
[8] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA
[9] Univ Alabama Birmingham, O Neal Comprehens Canc Ctr, Birmingham, AL USA
[10] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA USA
[11] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC USA
来源
SSM-MENTAL HEALTH | 2024年 / 6卷
基金
美国国家卫生研究院;
关键词
Ovarian cancer; Healthcare access; Racial disparities; Mental health; Mental health diagnosis; ETHNIC DISPARITIES; INSURANCE-COVERAGE; DEPRESSION; CARE; POPULATIONS; MORTALITY; DISTRESS; SURVIVAL; QUALITY; IMPACT;
D O I
10.1016/j.ssmmh.2024.100323
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Ovarian cancer (OC) patients have an increased risk for a mental health illness (MHI) after their cancer diagnosis, but limited research exists on whether this risk differs by race/ethnicity. Hence, we used SEERMedicare data to evaluate racial/ethnic differences in MHI incidence among OC patients aged 65+. Methods: Non-Hispanic (NH) Black, NH White, and Hispanic women diagnosed with OC in 2008-2015 without a mental health history 12 months prior to their cancer diagnosis were identified from SEER-Medicare. Cox proportional hazards regression evaluated new MHI incidence in the first five years post diagnosis and the differences by race/ethnicity. Hazard ratios (HR) and 95% confidence intervals (CI) adjusted for demographic/clinical covariates and healthcare access (HCA) dimensions. Results: We identified 5441 OC patients, including 364 NH Black (6.7%), 4982 NH White (91.6%), and 95 Hispanic (1.7%) patients. About 41% of NH White, 33.3% of NH Black, and 37.2% of Hispanic OC patients were diagnosed with MHI during the follow-up period between 2008 and 2016. In the fully adjusted model, NH Black OC patients were less likely to be diagnosed with any MHI (aHR: 0.67, 95% CI: 0.54, 0.82), depression (aHR: 0.66, 95% CI: 0.51, 0.86), and anxiety disorder (aHR: 0.64, 95% CI: 0.49, 0.84), while Hispanic OC patients were less likely to be diagnosed with anxiety disorder (aHR: 0.56, 95% CI: 0.33, 0.95) compared to NH White OC patients. Discussion: NH Black OC patients are less likely to receive a clinical MHI diagnosis compared to NH White OC patients. Further studies on racial differences in MHI incidence after OC diagnosis in primary cohorts are needed to better estimate population-level prevalence less vulnerable to exposure misclassification and to account for patient-level factors impacting MHI.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Thromboembolic Events Among Older Ovarian Cancer Patients: A SEER-Medicare Analysis
    Shantakumar, Sumitra
    Frost, Alexandra C.
    Li, Li
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 410 - 410
  • [2] Prevalence of preexisting mental illness in SEER-Medicare breast cancer patients.
    Haskins, Cole Brandon
    McDowell, Bradley D.
    Carnahan, Ryan
    Fiedorowicz, Jess
    Wallace, Robert B.
    Smith, Brian J.
    Chrischilles, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] THE INCIDENCE OF THROMBOCYTOPENIA AMONG OLDER PRIMARY MDS PATIENTS: A SEER-MEDICARE ANALYSIS
    Bennett, D.
    Shantakumar, S.
    Kobayashi, M.
    Wang, N.
    Snider, C.
    HAEMATOLOGICA, 2013, 98 : 431 - 432
  • [4] A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer patients
    Garcia, C.
    Yao, A.
    Camacho, F.
    Balkrishnan, R.
    Cantrell, L. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 146 - 147
  • [5] Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
    Ailawadhi, Sikander
    Parikh, Kejal
    Abouzaid, Safiya
    Zhou, Zhou
    Tang, Wenxi
    Clancy, Zoe
    Cheung, Claudia
    Zhou, Zheng-Yi
    Xie, Jipan
    BLOOD ADVANCES, 2019, 3 (20) : 2986 - 2994
  • [6] Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis
    Ailawadhi, Sikander
    Frank, Ryan D.
    Advani, Pooja
    Swaika, Abhisek
    Temkit, M'hamed
    Menghani, Richa
    Sharma, Mayank
    Meghji, Zahara
    Paulus, Shumail
    Khera, Nandita
    Hashmi, Shahrukh K.
    Paulus, Aneel
    Kakar, Tanya S.
    Hodge, David O.
    Colibaseanu, Dorin T.
    Vizzini, Michael R.
    Roy, Vivek
    Colon-Otero, Gerardo
    Chanan-Khan, Asher A.
    CANCER MEDICINE, 2017, 6 (12): : 2876 - 2885
  • [7] Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis
    Ailawadhi, Sikander
    Parikh, Kejal
    Zhou, Zhou
    Tang, Wenxi
    Clancy, Zoe
    Cheung, Claudia
    Zhou, Zheng-Yi
    Xie, Jipan
    Abouzaid, Safiya
    BLOOD, 2017, 130
  • [8] Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
    Wieder, Robert
    Adam, Nabil
    CANCERS, 2023, 15 (17)
  • [9] A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer
    Garcia, Christine
    Yao, Aaron
    Camacho, Fabian
    Balkrishnan, Rajesh
    Cantrell, Leigh A.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 346 - 350
  • [10] METABOLIC SYNDROME AND RISK OF OVARIAN CANCER IN THE UNITED STATES: AN ANALYSIS OF LINKED SEER-MEDICARE DATA
    Michels, Kara A.
    Trabert, Britton
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 34 - 34